PMCID: PMC10439806.
meningitidis activates both canonical and non-canonical pathways in the host, with predominance of the alternative caspase-3 mediated-GSDME activation in vitro in different cell lines (Tal et al., 2022) and of the GSDMD-dependent pathway in vivo in an intracisternal infected mouse model of meningitis (Pagliuca et al., 2024)
The Nano Microneedle Patch contains NIDDK-Tirzepatide in each patch
One area that has attracted academic discussion, press coverage, and significant biotechnology/pharma R&D investment is concern about undesirable, collateral skeletal muscle mass (SMM) loss, and presumably by extension, loss of strength and function in people taking GLP-1 medications
PlexusDx semaglutide injections from licensed 503A compounding pharmacies contain the same active pharmaceutical ingredient as brand products and follow identical biological timelines
More Helpful Articles Epitalon FDA Status 2026: What the Advisory Committee Vote Means Epitalon regulatory status as of July 28, 2026: Epitalon is not FDA-approved